|
|
Volumn 2012, Issue , 2012, Pages
|
|
Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature review
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
PROSTATE SPECIFIC ANTIGEN;
RADIOISOTOPE;
RADIOPHARMACEUTICAL AGENT;
RADIUM;
ADENOCARCINOMA;
BLOOD;
BONE;
BONE NEOPLASMS;
CASE REPORT;
CLINICAL TRIAL;
COMPLICATION;
DRUG EFFECTS;
DRUG RESISTANCE;
HUMAN;
MALE;
PAIN;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PROSTATIC NEOPLASMS;
SECONDARY;
ADENOCARCINOMA;
ALKALINE PHOSPHATASE;
BONE AND BONES;
BONE NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
PAIN;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RADIOISOTOPES;
RADIOPHARMACEUTICALS;
RADIUM;
|
|
EID: 84991329898
PISSN: None
EISSN: 1757790X
Source Type: Journal
DOI: 10.1136/bcr-2012-006540 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|